Aspirin Versus Aspirin+Clopidogrel as Antithrombotic Treatment Following TAVI "ARTE"

Active, not recruiting

Phase 4 Results N/A

Summary of Purpose

The purpose of this study is to compare aspirin/acetylsalicylic acid+ clopidogrel with aspirin/acetylsalicylic acid alone as antithrombotic treatment following TAVI for the prevention of major ischemic events (MI, ischemic stroke) or death without increasing the risk of major bleeding events.

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 10 May 2017.

1 Jan 2015 23 Dec 2015 1 Mar 2017 1 Mar 2018 1 May 2017 Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Design

  • Allocation: Randomized
  • Masking: Open Label
  • Purpose: Prevention
  • Endpoint: Safety/Efficacy Study
  • Intervention: Parallel Assignment

Contacts